资讯

News-Medical.Net on MSN8 小时
Targeting IGF2BP1 offers a new approach to cancer therapy
The RNA-binding protein IGF2BP1 has emerged as a key regulator of cancer hallmarks, influencing tumor proliferation, ...
AlphaGalileo17 小时
IGF2BP1: A Critical Driver of Cancer Progression and Therapeutic Target
The RNA-binding protein IGF2BP1 has emerged as a key regulator of cancer hallmarks, influencing tumor proliferation, ...
Labmate Online4 小时
EGFR inhibition alters metabolism in KRAS-mutant colon cancer
A new study [1] from the Medical University of Vienna has uncovered a surprising vulnerability in colorectal cancers driven ...